Severely recalcitrant pyoderma gangrenosum successfully treated with ustekinumab
- 30 November 2012
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 67 (5), e237-e238
- https://doi.org/10.1016/j.jaad.2012.04.045
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With UstekinumabArchives of Dermatology, 2011
- Pyoderma gangrenosum: A review and update on new therapiesJournal of the American Academy of Dermatology, 2010
- Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trialGut, 2006
- Treatment recommendations for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patientsJournal of the American Academy of Dermatology, 2005